MEDIM
ActiveMEDIM has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €766k and a net result of €167k. Equity is growing by ~49.6% per year across the filed fiscal years. Its solvency ranks better than 46% of 7921 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.1% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency51▲+20
Growth78=
Stability100
Bankruptcy probability, 12 months
1.1%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €45k at 30 days acceptable
Liquidity short (current ratio 0.22 against 0.44 in 2024), and 59.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
40.5%
Return on assets
8.8%
Age of the figures
8 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 5 filingsDeviation from the deadline
2025
7 d early
2024
11 d late
2023
7 d early
2022
31 d late
2021
31 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€766k▲ 28.0%
2024 · €599k
2021: €30k
2022: €183k
2023: €384k
2024: €599k
2021 → 2025
Total assets
€1.89M▼ 14.0%
2024 · €2.20M
2021: €875k
2022: €1.83M
2023: €2.35M
2024: €2.20M
2021 → 2025
Net result
€167k▼ 22.1%
2024 · €215k
2021: €-190k
2022: €153k
2023: €201k
2024: €215k
2021 → 2025
Working capital
€-354k▲ 26.6%
2024 · €-482k
2021: €-204k
2022: €-547k
2023: €-976k
2024: €-482k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€30k-€183k▲ 502%€384k▲ 110%€599k▲ 56.0%€766k▲ 28.0%
Operating result€-181k-€155k€235k▲ 51.8%€272k▲ 15.7%€258k▼ 5.1%
Net result€-190k-€153k€201k▲ 31.7%€215k▲ 6.9%€167k▼ 22.1%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 5% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.89M
Fixed assets
€1.79M▼ 1.4%
Current assets
€98k▼ 74.3%
Equity and liabilities €1.89M
Equity
€766k▲ 28.0%
Debt
€1.13M▼ 29.7%
The debt ratio falls from 72.8% to 59.5%: equity grows while debt is paid down.
Key figures and ratios
EBITDA
€334k▼
2024 · €346k
Cash flow
€243k▼
2024 · €289k
Solvency
40.5%▲
2024 · 27.2%
Current ratio
0.22▼
2024 · 0.44
Quick ratio
0.22▼
2024 · 0.44
Debt / equity
1.47▼
2024 · 2.68
ROE
21.9%▼
2024 · 35.9%
ROA
8.8%▼
2024 · 9.8%
Interest coverage
10.25▲
2024 · 7.86
Debt
€1.13M▼
2024 · €1.60M
Debt ≤ 1 year
€452k▼
2024 · €863k
Debt > 1 year
€668k▼
2024 · €732k
Income taxes
€58k▲
2024 · €13k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€2.20M€1.89M▼
Fixed assets21/28€1.82M€1.79M▼
Tangible fixed assets22/27€1.82M€1.79M▼
Land and buildings22€1.82M€1.79M▼
Current assets29/58€381k€98k▼
Amounts receivable within one year40/41€328k€56k▼
Trade receivables40€317k€49k▼
Other amounts receivable41€11k€7k▼
Cash at bank and in hand54/58€53k€40k▼
Deferred charges and accrued income490/1-€2k
Equity and liabilities
Total equity and liabilities10/49€2.20M€1.89M▼
Equity10/15€599k€766k▲
Contributions10/11€220k€220k=
Reserves13€379k€546k▲
Distributable reserves133€379k€546k▲
Amounts payable17/49€1.60M€1.13M▼
Amounts payable after more than one year17€732k€668k▼
Financial debts170/4€732k€668k▼
Amounts payable within one year42/48€863k€452k▼
Current portion of amounts payable after more than one year42€63k€64k▲
Financial debts43-€13k
Credit institutions430/8-€13k
Trade debts44€4k€3k▼
Suppliers440/4€4k€3k▼
Taxes, remuneration and social security45€16k€14k▼
Taxes450/3€14k€14k▼
Remuneration and social security454/9€2k-
Other amounts payable47/48€780k€358k▼
Accrued charges and deferred income492/3€7k€7k=
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€74k€76k▲
Other operating charges640/8€9k€16k▲
Gross operating margin9900€355k€350k▼
Operating profit (loss)9901€272k€258k▼
Financial income75/76B€0-
Recurring financial income75€0-
Financial charges65/66B€44k€33k▼
Recurring financial charges65€44k€33k▼
Profit (loss) for the period before taxes9903€228k€225k▼
Income taxes67/77€13k€58k▲
Profit (loss) for the period9904€215k€167k▼
Profit (loss) for the period to be appropriated9905€215k€167k▼
Appropriation of the result
Profit (loss) to be appropriated9906€215k€167k▼
Profit (loss) brought forward from the previous period14P€0-
Transfer to equity691/2€215k€167k▼
To other reserves6921€215k€167k▼
Social balance
Average headcount (FTE)90870.0-
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
24-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
11-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 11 days late
2024
31-12
Financial
Highest result since 2021net €215k ▲6.9%
Operating result €272k, net result €215k, both a record.
31-12
Financial
Equity above €500kEq €599k ▲56%
3 profitable years in a row build equity to €599k.
24-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Equity above €200kEq €384k ▲110%
2 profitable years in a row build equity to €384k.
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 31 days late
2022
31-12
Financial
Back to profitnet €153k
Net result €153k after one loss-making year.
31-12
Financial
Equity above €150kEq €183k ▲502%
Equity rises from €30k to €183k.
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kruisem · 1 establishment unit since 2020
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Landegemstraat 199750 KruisemGround area
3,815 m²
Building footprint
961 m²
Volume, LiDAR
1,857 m³
2 parcels, Flanders · tallest building 11.4 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
MEDIM
since 20202.301.113.875
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34452B0804/00K000 | Flanders | 2,443 m² | 1 · 846 m² | 7.1 m · 1 fl. |
| 45036A0936/00G000 | Flanders | 1,372 m² | 1 · 115 m² | 11.4 m · 1 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
SENOR
BE 0886.286.822
Ronse · Eq €763k
VALERCO
BE 0478.658.475
Kontich · Eq €771k
RESEARCH, DEVELOPMENT AND SALES FOR MEDECINE
BE 0453.323.857
Hasselt · Eq €771k
Farmadistri
BE 0716.742.995
Oudenburg · Eq €760k
STERIMED
BE 0862.447.784
Riemst · Eq €759k
Of 1,894 companies in sector 46460 we hold annual accounts for 1,114. 762 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded09-04-2020
Fiscal year end31-12
Activities, NACEBEL
46460Wholesale of pharmaceutical and medical goods
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers
Data from official sources, last processed on 13-09-2026. Scores and ratios are computed by Checked and are not a credit decision.